Literature DB >> 26108064

The risk of chronic kidney disease in a metabolically healthy obese population.

Chang Hee Jung1, Min Jung Lee1, Yu Mi Kang1, Jenie Y Hwang2, Eun Hee Kim2, Joong-Yeol Park1, Hong-Kyu Kim2, Woo Je Lee1.   

Abstract

Obesity has become an important risk factor for chronic kidney disease (CKD). The metabolically healthy obese (MHO) phenotype refers to obese individuals with a favorable metabolic profile. However, its prognostic value remains controversial and may depend on the health outcome being investigated. To assess this, we examined the risk of MHO phenotype with incident CKD in a Korean population of 41,194 people without CKD. Individuals were stratified by body mass index (cutoff value, 25.0 kg/m(2)) and metabolic health state (assessed using Adult Treatment Panel-III criteria). Incident CKD was defined as a glomerular filtration rate of <60 ml/min per 1.73 m(2) calculated using the Chronic Kidney Disease Epidemiology Collaboration equation. Over the median follow-up period of 38.7 months, 356 of the individuals developed incident CKD. Compared with the metabolically healthy nonobese (MHNO) group, the MHO group showed increased risk of incident CKD with a multivariate-adjusted hazard ratio of 1.38 (95% CI, 1.01-1.87). Nonobese but metabolically unhealthy individuals were at an increased risk of incident CKD (multivariate-adjusted hazard ratio, 1.37 (95% CI, 1.02-1.93)) than the MHNO group. Metabolically unhealthy obese individuals were at the highest risk of incident CKD. Thus, a healthy metabolic profile does not protect obese adults from incident CKD. Hence, it is important to consider metabolic health along with obesity when evaluating CKD risk.

Entities:  

Mesh:

Year:  2015        PMID: 26108064     DOI: 10.1038/ki.2015.183

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  57 in total

1.  A SAS(®) macro implementation of a multiple comparison post hoc test for a Kruskal-Wallis analysis.

Authors:  Alan C Elliott; Linda S Hynan
Journal:  Comput Methods Programs Biomed       Date:  2010-12-10       Impact factor: 5.428

2.  Metabolically healthy obesity: different prevalences using different criteria.

Authors:  S Velho; F Paccaud; G Waeber; P Vollenweider; P Marques-Vidal
Journal:  Eur J Clin Nutr       Date:  2010-07-14       Impact factor: 4.016

3.  Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS).

Authors:  N Furusyo; T Koga; M Ai; S Otokozawa; T Kohzuma; H Ikezaki; E J Schaefer; J Hayashi
Journal:  Diabetologia       Date:  2011-09-27       Impact factor: 10.122

4.  Body mass index and the risk of development of end-stage renal disease in a screened cohort.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Kozen Kinjo; Taku Inoue; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

5.  Metabolic abnormalities, but not obesity, contribute to the mildly reduced eGFR in middle-aged and elderly Chinese.

Authors:  Chuan Wang; Kai Liang; Xiuping Zhang; Chengqiao Li; Weifang Yang; Zeqiang Ma; Yu Sun; Jun Song; Peng Lin; Lei Gong; Meijian Wang; Fuqiang Liu; Wenjuan Li; Juan Xiao; Fei Yan; Junpeng Yang; Lingshu Wang; Meng Tian; Jidong Liu; Ruxing Zhao; Xinguo Hou; Li Chen
Journal:  Int Urol Nephrol       Date:  2014-08-07       Impact factor: 2.370

6.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

Authors:  Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers
Journal:  Arch Intern Med       Date:  2008-08-11

Review 7.  Obesity and kidney disease: potential mechanisms.

Authors:  Christopher Wickman; Holly Kramer
Journal:  Semin Nephrol       Date:  2013-01       Impact factor: 5.299

8.  Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study.

Authors:  Marc M H Hermans; Ronald Henry; Jacqueline M Dekker; Jeroen P Kooman; Piet J Kostense; Giel Nijpels; Robert J Heine; Coen D A Stehouwer
Journal:  J Am Soc Nephrol       Date:  2007-04-25       Impact factor: 10.121

9.  Mild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calcium.

Authors:  Sion K Roy; Albert Cespedes; Dong Li; Tae-Young Choi; Matthew J Budoff
Journal:  Vasc Health Risk Manag       Date:  2011-12-02

Review 10.  Relationship between chronic kidney disease and metabolic syndrome: current perspectives.

Authors:  Khaled Nashar; Brent M Egan
Journal:  Diabetes Metab Syndr Obes       Date:  2014-09-18       Impact factor: 3.168

View more
  28 in total

1.  The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects.

Authors:  Da Young Lee; Jae Hwan Jee; Ji Eun Jun; Tae Hyuk Kim; Sang-Man Jin; Kyu Yeon Hur; Sun Wook Kim; Jae Hoon Chung; Moon-Kyu Lee; Jae Hyeon Kim
Journal:  Endocrine       Date:  2016-10-05       Impact factor: 3.633

2.  Relationships Between Metabolic Body Composition Status and Rapid Kidney Function Decline in a Community-Based Population: A Prospective Observational Study.

Authors:  Shao-Chi Chu; Po-Hsi Wang; Kuan-Ying Lu; Chia-Chun Ko; Yun-Hsuan She; Chin-Chan Lee; I-Wen Wu; Chiao-Yin Sun; Heng-Jung Hsu; Heng-Chih Pan
Journal:  Front Public Health       Date:  2022-06-03

3.  Metabolic obesity phenotypes and chronic kidney disease: a cross-sectional study from the RaNCD cohort study.

Authors:  Samira Arbabi Jam; Behrooz Moloudpour; Farid Najafi; Mitra Darbandi; Yahya Pasdar
Journal:  BMC Nephrol       Date:  2022-07-01       Impact factor: 2.585

4.  Cardiometabolic Risk Factors, Metabolic Syndrome, and Chronic Kidney Disease Progression in Children.

Authors:  Shwetal Lalan; Shuai Jiang; Derek K Ng; Fernanda Kupferman; Bradley A Warady; Susan Furth; Mark M Mitsnefes
Journal:  J Pediatr       Date:  2018-07-02       Impact factor: 4.406

5.  Association Between Serum Albumin Levels and Obesity and Risk of Developing Chronic Kidney Disease Using Data from the Korean Multi-Rural Communities Cohort (MRCohort) Population Database.

Authors:  Kwang Ho Mun
Journal:  Med Sci Monit       Date:  2021-08-16

6.  Association between Obese Phenotype and Mildly Reduced eGFR among the General Population from Rural Northeast China.

Authors:  Shasha Yu; Hongmei Yang; Xiaofan Guo; Liqiang Zheng; Yingxian Sun
Journal:  Int J Environ Res Public Health       Date:  2016-05-27       Impact factor: 3.390

7.  How central obesity influences intra-abdominal pressure: a prospective, observational study in cardiothoracic surgical patients.

Authors:  Marije Smit; Maureen J M Werner; Annemieke Oude Lansink-Hartgring; Willem Dieperink; Jan G Zijlstra; Matijs van Meurs
Journal:  Ann Intensive Care       Date:  2016-10-10       Impact factor: 6.925

8.  Consequences of morbid obesity on the kidney. Where are we going?

Authors:  Maruja Navarro Díaz
Journal:  Clin Kidney J       Date:  2016-09-20

9.  Visceral Adiposity Index and Lipid Accumulation Product Index: Two Alternate Body Indices to Identify Chronic Kidney Disease among the Rural Population in Northeast China.

Authors:  Dongxue Dai; Ye Chang; Yintao Chen; Shuang Chen; Shasha Yu; Xiaofan Guo; Yingxian Sun
Journal:  Int J Environ Res Public Health       Date:  2016-12-13       Impact factor: 3.390

10.  Weight change and microvascular outcomes in patients with new-onset diabetes: a nationwide cohort study.

Authors:  Eun Sil Koh; Kyung Do Han; Mee Kyoung Kim; Eun Sook Kim; Min-Kyung Lee; Ga Eun Nam; Hyuk-Sang Kwon
Journal:  Korean J Intern Med       Date:  2021-05-13       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.